ArticleNucleic acids research2025
Methylglyoxal mutagenizes single-stranded DNA via Rev1-associated slippage and mispairing.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Graphene Oxide and Methylglyoxal: a combined strategy against chronic wound pathogens.Applied microbiology and biotechnology · 2026Article
- Microbiota and Methylglyoxal-Derived AGEs: Implications in Ageing and Age-Related Disease.Life (Basel, Switzerland) · 2026Review
- Aldehyde Detoxification in Cancer: Metabolic Guardians of the Genome.Biomolecules · 2026Review
- Metformin-like Methylglyoxal Scavengers from MacroalgaeMarine drugs · 2026Article
- Review
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Methylglyoxal (MG) is a highly reactive aldehyde that is produced endogenously during metabolism, and from exogenous sources like sugary food and cigarette smoke. Unless detoxified by glyoxalases, MG can readily react with DNA and proteins, generating characteristic glycation-derived lesions. As a result, MG exposure has been linked to a variety of human diseases, including cancers. Prior studies show that MG preferentially makes adducts on guanine residues, causing DNA damage. However, in vivo, how such events impact genome-wide MG mutagenicity is poorly understood. Such information is essential to comprehend the true contribution of MG to genome instability and global mutational burden. In the present study, we show that MG can robustly mutagenize single-stranded DNA in the yeast genome, within a guanine-centered mutable motif. We demonstrate that genome-wide MG mutagenesis is greatly elevated in the absence of the glyoxalase Glo1, and abrogated in the presence of the aldehyde quencher aminoguanidine. Importantly, we uncovered strand slippage and mispairing as the predominant mechanism for generation of all MG-associated mutations, and demonstrate that the translesion polymerase Rev1 is a key player in this pathway. Finally, we find that the primary MG-associated mutation is enriched in a variety of sequenced tumor datasets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.